Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
Century Therapeutics $242.7 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Cyteir Therapeutics $133.2 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Convey Holding Parent $186.7 million IPO
We advised the underwriters on the IPO and NYSE listing
Molecular Partners $64 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
Lydall $1.3 billion acquisition by Unifrax
We are advising Lydall on the transaction
Codere Online business combination with DD3 Acquisition Corp. II
We are advising Codere Online on its combination with a SPAC
Raven Industries $2.1 billion acquisition by CNH Industrial
We are advising Raven Industries on the transaction
Mitsubishi HC Capital acquisition of CAI International
We are advising Mitsubishi HC Capital on the acquisition
TaskUs $303.6 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Ferrero-related company acquisition of Burton’s Biscuit Company
We are advising the Ferrero-related company on the acquisition